Content-Length: 269677 | pFad | http://sh.wikipedia.org/wiki/Mosaprid

Mosaprid – Wikipedija/Википедија Prijeđi na sadržaj

Mosaprid

Izvor: Wikipedija
Mosaprid
(IUPAC) ime
(RS)-4-amino-5-hloro-2-etoksi-N[4-(4-fluorobenzil)morfolin-2-il]metil
Klinički podaci
Identifikatori
ATC kod ?
Hemijski podaci
Formula ?
Farmakoinformacioni podaci
Trudnoća ?
Pravni status

benzamid

| image = Mosapride.svg | width = 180 | image2 = 3D Mosapride.png | width2 =

| tradename = | Drugs.com = Internacionalno ime leka | pregnancy_AU = | pregnancy_US = | pregnancy_category = | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_status = | routes_of_administration =

| bioavailability = | protein_bound = | metabolism = | elimination_half-life = | excretion =

| CAS_number_Ref =  DaY | CAS_number = 112885-41-3 | ATC_prefix = none | ATC_suffix = | PubChem = 119584 | IUPHAR_ligand = 242 | DrugBank_Ref = Šablon:Drugbankcite | DrugBank = | ChemSpiderID_Ref =  DaY | ChemSpiderID = 106780 | UNII_Ref =  DaY | UNII = I8MFJ1C0BY | KEGG_Ref =  DaY | KEGG = D08236 | ChEMBL_Ref =  DaY | ChEMBL = 60889

| C=21 | H=25 | Cl=1 | F=1 | N=3 | O=3 | molecular_weight = 421,893 g/mol | smiles = Clc1cc(c(OCC)cc1N)C(=O)NCC3OCCN(Cc2ccc(F)cc2)C3 | InChI = 1/C21H25ClFN3O3/c1-2-28-20-10-19(24)18(22)9-17(20)21(27)25-11-16-13-26(7-8-29-16)12-14-3-5-15(23)6-4-14/h3-6,9-10,16H,2,7-8,11-13,24H2,1H3,(H,25,27) | InChIKey = YPELFRMCRYSPKZ-UHFFFAOYAO | StdInChI_Ref =  DaY | StdInChI = 1S/C21H25ClFN3O3/c1-2-28-20-10-19(24)18(22)9-17(20)21(27)25-11-16-13-26(7-8-29-16)12-14-3-5-15(23)6-4-14/h3-6,9-10,16H,2,7-8,11-13,24H2,1H3,(H,25,27) | StdInChIKey_Ref =  DaY | StdInChIKey = YPELFRMCRYSPKZ-UHFFFAOYSA-N | synonyms = }} Mosaprid je gastroprokinetički agens koji deluje kao selektivni 5HT4 agonist[1] koji ubrzava gastrično pražnjenje i koristi se za tretman kiselinskog refluksa[2], sindroma iritabilnih creva i funkcionalnu dispepsiju.[3] Njegova česta sporedna dejstva su dijareja, abdomenalni bol, vrtoglavica, konstipacija, glavobolja, insomnija, i mučnina.[4]

Reference

[uredi | uredi kod]
  1. Kato S, Morie T, Yoshida N. Synthesis and biological activities of metabolites of mosapride, a new gastroprokinetic agent. Chemical and Pharmaceutical Bulletin (Tokyo). 1995 Apr;43(4):699-702.
  2. Ruth M, Hamelin B, Rohss K, Lundell L. The effect of mosapride, a novel prokinetic, on acid reflux variables in patients with gastro-oesophageal reflux disease. Alimentary Pharmacology and Therapeutics. 1998 Jan;12(1):35-40.
  3. Mizuta Y, Shikuwa S, Isomoto H, Mishima R, Akazawa Y, Masuda J, Omagari K, Takeshima F, Kohno S. Recent insights into digestive motility in functional dyspepsia. Journal of Gastroenterology. 2006 Nov;41(11):1025-40.
  4. Mosapride drug information - Drugs Update India

Vanjske veze

[uredi | uredi kod]








ApplySandwichStrip

pFad - (p)hone/(F)rame/(a)nonymizer/(d)eclutterfier!      Saves Data!


--- a PPN by Garber Painting Akron. With Image Size Reduction included!

Fetched URL: http://sh.wikipedia.org/wiki/Mosaprid

Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy